Coherus Oncology, Inc. (FRA:8C5)
1.459
+0.259 (21.58%)
At close: Jan 9, 2026
-8.70% (1Y)
| Market Cap | 175.61M |
| Revenue (ttm) | 236.71M |
| Net Income (ttm) | 132.08M |
| Shares Out | n/a |
| EPS (ttm) | 1.14 |
| PE Ratio | 1.33 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 900 |
| Average Volume | 221 |
| Open | 1.294 |
| Previous Close | 1.200 |
| Day's Range | 1.294 - 1.459 |
| 52-Week Range | 0.608 - 1.571 |
| Beta | n/a |
| RSI | 68.92 |
| Earnings Date | Mar 6, 2026 |